Figure 3 Rett syndrome severity and age at diagnosis by mutation type

Slides:

Advertisements

Similar presentations

Clinical variability and relationship with genotype in Rett syndrome:insights from AussieRett and InterRett Telethon Institute for Child Health Research.

Advertisements

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Nat. Rev. Neurol. doi:10/1038/nrneurol

Figure 2 Electromechanical properties of OIHPs

Figure 4 Progression-free survival, according to treatment group

Figure 3 Life expectancy at birth in all countries included

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 The US Centers for Disease Control and

Figure 4 Time course of the development of physiological changes

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 4 Host damage from infection-related inflammatory

Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 4 Cerebrospinal fluid levels of neurofilament light chain

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 8 Implanted devices for the management of heart failure

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Proportion of patients for whom NEDA

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Diagnostic tiers of Parkinson disease as single disease

Figure 1 Schematic overview of the LGI1 protein in the synapse

Figure 2 Grey matter atrophy in FTD

Figure 1 Associations between baseline cerebrospinal fluid

Figure 1 Osteosarcoma epidemiology

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Allele frequency and effect size for ALS-associated genes

Figure 2 Algorithm for immunosuppressive treatment

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Principles of therapeutic ultrasound

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Clinical correlates of neurodegeneration in MS

Figure 3 Genetic pleiotropy in ALS

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Evolution of multiple sclerosis

Figure 2 Haemorrhagic stroke prevalence and mortality

Figure 1 The trajectory of cognitive ageing

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Stroke-related deaths and DALYs by country development status

the SNP profile using 26 prostate cancer GWAS risk SNPs

Nat. Rev. Neurol. doi: /nrneurol

Figure 6 Combining population-wide and high-risk strategies

Figure 1 Ischaemic stroke prevalence and mortality

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Potential interplay between physiological

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Chromosomal region 15q11.2–q13

Figure 1 Clinical aspects of LGMD subtypes

Figure 1 The VEGF family of growth factors

MicroRNAs in Memory Processing

Figure 2 Dzyaloshinskii–Moriya interactions

Figure 3 Overall survival, according to treatment group

Nat. Rev. Neurol. doi: /nrneurol

Figure 3.3. Change in average annual runoff by the 2050s under the SRES A2 emissions scenario and different climate models (Arnell,

Figure 5 Interaction between infarction and amyloid deposition

Figure 1 A large number of genes are potentially associated with CIPN

Figure 4 The relationship between the time-dependent changes in the expression of immunoglobulin, mast cell, acute kidney injury (AKI), and fibrillar collagen.

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Neurol. doi: /nrneurol

Modeling Rett Syndrome with Stem Cells

Nat. Rev. Neurol. doi: /nrneurol

Figure 4 4D printing schemes and time-evolving structure geometries

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Seizure outcomes

Figure 2 Network connections of the hypothalamus

Figure 2 Diffusio-osmotic process for osmotic energy conversion

Nat. Rev. Mater. doi: /natrevmats

Presentation transcript:

Figure 3 Rett syndrome severity and age at diagnosis by mutation type Figure 3 | Rett syndrome severity and age at diagnosis by mutation type. a | Association between clinical severity and methyl-CpG-binding protein 2 (MECP2) mutation type in 974 individuals with Rett syndrome (RTT) assessed via the Percy score, and 776 assessed via the Pineda score. Data points are the mean scores adjusted for age and data source, with 95% confidence intervals. Permission obtained from Macmillan Publishers Ltd © Bebbington, A. Eur. J. Hum. Genet. 20, 921–927 (2012)129. b | Age at diagnosis by mutation type in 1,040 individuals with RTT. Data points indicate the median age. Data from the Australian and International Rett Syndrome (InterRett) databases. Permission obtained from Macmillan Publishers Ltd © Bebbington, A. Eur. J. Hum. Genet. 20, 921–927 (2012). Leonard, H. et al. (2016) Clinical and biological progress over 50 years in Rett syndrome Nat. Rev. Neurol. doi:10.1038/nrneurol.2016.186